Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
The 2025 Chinese Congress on Holistic Integrative Oncology (CCHIO) will be held in Kunming, presenting a new landscape of integrated cancer prevention and treatment from a global perspective. 2025-11-06 10:58
Natural Field will Launch "Ashwagandha White Paper" at FTA Forum in Hangzhou 2025-11-05 23:00
IDT Biologika Accelerates Global CDMO Expansion Manufacturing capabilities highlighted through consecutive participation in WVC, CPHI and BIO-Europe 2025 2025-11-05 21:00
BioDlink Congratulates Lepu Biopharma on Securing Approval for the World's First Approved EGFR-Targeted ADC 2025-11-05 21:00
Nona Biosciences Announces Expansion of Collaboration with Umoja Biopharma to Advance In Vivo CAR-T Cell Therapies 2025-11-05 20:07
HanchorBio Presents Preclinical Data on HCB301 at SITC 2025 2025-11-05 20:00
Zepp Health Corporation Reports Third Quarter 2025 Unaudited Financial Results 2025-11-05 09:15
Health In Tech Announces New Davos 2026 Panel: "First Ladies: Backing Women Who Build" Featuring Cherie Blair CBE, KC 2025-11-05 07:48
Grit Biotherapeutics Invited to Deliver Oral Presentation at ASH 2025 on Breakthrough In Vivo CAR-T Therapy GT801 2025-11-04 21:15
LakeShore Biopharma Enters into Definitive Agreement for Going-Private Transaction 2025-11-04 20:04
Sky Labs Attracts Investment With Omron Subsidiary 'OMRON VENTURES' 2025-11-04 19:25
CARsgen Announces Positive Clinical Data for Allogeneic CAR-T Products CT0596 and CT1190B 2025-11-03 22:15
Sanyou Bio and Shanghai ZJ Bio-Tech Sign Strategic Cooperation Agreement on Automated Development of Innovative Biologics to Jointly Tackle R&D Bottlenecks and Provide New Momentum for Innovative Drug R&D 2025-11-03 22:00
EmeTerm Wristband Significantly Reduces Postoperative Nausea and Vomiting in Major Orthopedic Surgeries 2025-11-03 22:00
Samsung Biologics completes spin-off to strengthen its focus as a pure-play CDMO 2025-11-03 20:00
GC Biopharma's Recombinant Anthrax Vaccine, BARYTHRAX, Demonstrates Safety and Immunogenicity in Phase 2 Data, Published in 'Vaccine' 2025-11-03 13:26
Akeso's Ivonescimab Secures Fourth Breakthrough Therapy Designation in China for First-Line Treatment of Triple-Negative Breast Cancer 2025-11-03 12:12
Zhimeng Biopharma's investigational drug CB03-154 for amyotrophic lateral sclerosis has achieved the first patient first dose milestone in the phase 2/3 pivotal clinical trial. 2025-10-31 21:00
Alpha Fusion Initiates Company-Sponsored Clinical Trial of Alpha-Emitting Radiopharmaceutical af-001 in Patients with Differentiated Thyroid Cancer 2025-10-31 20:00
U.S. FDA grants interchangeability designation to Celltrion's denosumab biosimilars, STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) 2025-10-30 15:28
1 7 8 9 10 11 888